Examkin

Question

Difficulty: MediumImmunizations and Vaccine-Preventable Diseases

A 32-year-old primigravid woman at 28 weeks gestation presents for a routine prenatal visit. Her pregnancy has been uncomplicated. She feels well and reports normal fetal movement. Vital signs are temperature 37.1°C (98.8°F), blood pressure 118/76 mmHg, pulse 82/min, and respirations 14/min. Physical examination is unremarkable, and the fundal height is 28 cm. A review of her medical records shows that she received all routine childhood vaccinations. Notably, she received a tetanus and diphtheria (Td) toxoids booster 2 years ago after sustaining a superficial laceration while gardening. She asks whether she needs any immunizations during today's visit. Which of the following is the most appropriate next step regarding this patient's immunizations?

  1. Administer the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine.Answer
  2. B
    Defer the Tdap vaccine because she received a Td booster within the past 5 years.
  3. C
    Defer all immunizations until the postpartum period to avoid teratogenic risk.
  4. D
    Administer the measles, mumps, and rubella (MMR) vaccine.
  5. E
    Administer the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Answer

Administer the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine.
The tetanus, diphtheria, and acellular pertussis (Tdap) vaccine is recommended for all pregnant women during every pregnancy, optimally between 27 and 36 weeks of gestation. The primary physiological goal of this recommendation is to maximize the maternal antibody response against pertussis and facilitate the transplacental transfer of these protective IgG antibodies to the fetus. This provides the neonate with crucial passive immunity against whooping cough during the first few vulnerable months of life, prior to the initiation of their own primary DTaP vaccination series. This recommendation applies regardless of when the patient last received a Td or Tdap vaccine. Therefore, the fact that this patient received a Td booster 2 years ago does not change the current indication to administer Tdap.

Step-by-Step Solution

1
Evaluate the patient's current gestational age and vaccination history.
The patient is at 28 weeks gestation and received a Td booster 2 years ago.
Gestational age determines the timing for routine prenatal interventions, and vaccination history is needed to assess for potential contraindications or perceived redundancies.
2
Determine the indications for the Tdap vaccine in pregnancy.
Guidelines state that Tdap should be administered during every pregnancy between 27 and 36 weeks gestation.
This timing maximizes the maternal antibody response and the transplacental transfer of protective IgG antibodies against pertussis to the fetus.
3
Assess whether the prior Td booster changes the recommendation.
The prior Td booster 2 years ago does not alter the recommendation; Tdap is still required now.
The primary goal is fetal protection against pertussis in the neonatal period, not solely maternal tetanus prophylaxis.

Key Concept

The Tdap vaccine is recommended for all pregnant women during every pregnancy, optimally between 27 and 36 weeks gestation, regardless of the interval since their last tetanus or diphtheria-containing vaccine.
Rate this question

Topics

Immunizations and Vaccine-Preventable Diseases

More questions from this topic